IP Library Granted Patent US 12,280,261
Granted Patent B2
US 12,280,261 · App. 17/645,682 · Granted Apr 22, 2025

Medical device patient alert using housing stimulation based on sensed event

Inventors: Jonathon E. Giftakis (Maple Grove, MN); Scott R. Stanslaski (Shoreview, MN); William C. Harding (Chandler, AZ); Ryan Gertenbach (Chandler, AZ); Brian L. Bechard (St. Paul, MN); Nathan A. Torgerson (Andover, MN)
Assignee: Medtronic, Inc.
A61N1/37258A61N1/025A61N1/0551A61N1/08A61N1/36175
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,280,261
App. No.
17/645,682
Granted
Apr 22, 2025
Kind
B2
Abstract

An implantable medical device that includes a memory, stimulation circuitry configured to deliver electrical stimulation to a patient, and processing circuitry operably coupled to the memory. The processing circuitry is configured to: control the stimulation circuitry to output electrical stimulation therapy to a patient via a first electrode combination and control the stimulation circuitry to output a notification stimulation via a second electrode combination and interleaved with the electrical stimulation therapy. The notification stimulation may include an intensity above a perception level of the patient, and the second electrode combination may include an electrode disposed at an implant site of the implantable medical device.

Claims (46)

1. An implantable medical device comprising:

a memory;

stimulation circuitry configured to deliver electrical stimulation to a patient; and

processing circuitry operably coupled to the memory and configured to:

control the stimulation circuitry to output electrical stimulation therapy to a patient via a first electrode combination, wherein the electrical stimulation therapy comprises a first plurality of pulses, wherein the first plurality of pulses are output at a pulse rate; and

control the stimulation circuitry to output a notification stimulation defined by a predetermined pattern of a second plurality of pulses via a second electrode combination, wherein the second plurality of pulses are interleaved with at least some pulses of the first plurality of pulses of the electrical stimulation therapy to maintain the predetermined pattern of the second plurality of pulses,

wherein the notification stimulation comprises an intensity above a perception level of the patient,

wherein the notification stimulation comprises an acknowledgement notification to a communication from the patient, and

wherein the second electrode combination comprises an electrode disposed at an implant site of the implantable medical device.

2. The implantable medical device of claim 1 ,

wherein a housing of the implantable medical device comprises the electrode disposed at the implant site, and

wherein the electrode disposed at the implant site acts as a cathode for the notification stimulation delivered by the stimulation circuitry.

3. The implantable medical device of claim 1 , wherein the notification stimulation comprises a change in stimulation that causes a side effect perceptible to the patient.

4. The implantable medical device of claim 1 , wherein an electrode integrated with the housing of the implantable medical device but electrically isolated from the housing acts as a cathode to deliver the notification stimulation.

5. The implantable medical device of claim 1 , wherein an electrode on a lead implanted proximal to the implant site acts as a cathode to deliver the notification stimulation.

6. The implantable medical device of claim 1 , wherein the second electrode combination comprises one or more electrodes implanted separate from the implant site and configured to act as one or more anodes for the notification stimulation.

7. The implantable medical device of claim 1 , wherein the second plurality of pulses is detectable by the patient as the notification stimulation.

8. The implantable medical device of claim 7 , wherein the processing circuitry is configured to control the stimulation circuitry to deliver the second plurality of pulses at a predetermined pulse repetition rate.

9. The implantable medical device of claim 7 ,

wherein the second plurality of pulses comprises a first period of time between a first pulse and a second pulse of a plurality of pulses and a second period of time between the second pulse and a third pulse, and

wherein the first period is longer than the second period.

10. The implantable medical device of claim 7 ,

wherein the second plurality of pulses detectable by the patient comprise a first pulse at a first magnitude and a second pulse at a second magnitude, and

wherein the first magnitude is greater than the second magnitude.

11. The implantable medical device of claim 7 , wherein the second plurality of pulses detectable by the patient comprise a gradually increasing magnitude for each pulse of the second plurality of pulses over a predetermined duration.

12. The implantable medical device of claim 1 , wherein the electrical stimulation therapy comprises spinal cord stimulation, and wherein the first electrode combination comprises one or more electrodes configured to be implanted adjacent the spinal cord.

13. The implantable medical device of claim 1 , wherein the electrical stimulation therapy comprises tibial therapy stimulation, and wherein the first electrode combination comprises one or more electrodes configured to be implanted adjacent to a tibial nerve.

14. A method comprising:

controlling, by processing circuitry operably coupled to a memory, stimulation circuitry configured to output electrical stimulation therapy to a patient; and

controlling, by the processing circuitry, the stimulation circuitry to output the electrical stimulation therapy to a patient via a first electrode combination, wherein the electrical stimulation therapy comprises a first plurality of pulses, wherein the first plurality of pulses are output at a pulse rate; and

controlling, by the processing circuitry, the stimulation circuitry to output a notification stimulation defined by a predetermined pattern of a second plurality of pulses, wherein the second plurality of pulses are interleaved with at least some of the first plurality of pulses of the electrical stimulation therapy to maintain the predetermined pattern of the second plurality of pulses via a second electrode combination,

wherein the notification stimulation comprises an intensity above a perception level of the patient,

wherein the notification stimulation comprises an acknowledgement notification to a communication from the patient, and

wherein the second electrode combination comprises an electrode disposed at an implant site of the implantable medical device.

15. The method of claim 14 , wherein a housing of the implantable medical device comprises the electrode disposed at the implant site.

16. The method of claim 14 , wherein the electrode disposed at the implant site acts as a cathode for the notification stimulation delivered by the stimulation circuitry.

17. The method of claim 14 , wherein an electrode on a lead implanted proximal to the implant site acts as a cathode to deliver the notification stimulation.

18. The method of claim 14 , wherein the second plurality of pulses is detectable by the patient as the notification stimulation.

19. The method of claim 18 ,

wherein the second plurality of pulses detectable by the patient comprise a first pulse at a first magnitude and a second pulse at a second magnitude, and

wherein the first magnitude is greater than the second magnitude.

20. The method of claim 14 , wherein the electrical stimulation therapy comprises spinal cord stimulation, and wherein the first electrode combination comprises one or more electrodes configured to be implanted adjacent the spinal cord.

21. A non-transitory computer-readable storage medium comprising instructions for causing a programmable processor of a medical device to control stimulation circuitry, wherein the stimulation circuitry is configured to:

output electrical stimulation therapy to a patient, wherein the electrical stimulation therapy comprises a first plurality of pulses, wherein the first plurality of pulses are output at a pulse rate; and

output a notification stimulation defined by a predetermined pattern of a second plurality of pulses, wherein the second plurality of pulses are interleaved with at least some of the first plurality of pulses of the electrical stimulation therapy to maintain the predetermined pattern of the second plurality of pulses,

wherein the notification stimulation comprises a housing stimulation at an implant site of the implantable medical device, wherein the housing stimulation comprises stimulation above a perception level of the patient, and wherein the notification stimulation comprises an acknowledgement notification to a communication from the patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2021
From: GIFTAKIS, JONATHON E.; STANSLASKI, SCOTT R.; HARDING, WILLIAM C.; GERTENBACH, RYAN; BECHARD, BRIAN L.; TORGERSON, NATHAN A.
To: MEDTRONIC, INC.
Reel/Frame 058569/0056 →
Continuity (2)
Provisional Application 63152930 · Feb 24, 2021
Related Publication 20220266041A1 · Aug 25, 2022
References Cited (69)
US 4140131A · Dutcher et al. · 1979 [cited by applicant]
US 5304206A · Baker, Jr. et al. · 1994 [cited by applicant]
US 6080187A · Alt et al. · 2000 [cited by applicant]
US 7574259B1 · Pei et al. · 2009 [cited by applicant]
US 7606618B1 · Bornzin et al. · 2009 [cited by applicant]
US 7672716B1 · Koh · 2010 [cited by applicant]
US 7734345B2 · Cinbis · 2010 [cited by applicant]
US 7774056B2 · Torgerson · 2010 [cited by applicant]
US 7962210B2 · Daum et al. · 2011 [cited by applicant]
US 7996084B2 · Stylos et al. · 2011 [cited by applicant]
US 8121691B2 · Gerber et al. · 2012 [cited by applicant]
US 8145320B2 · Corndorf et al. · 2012 [cited by applicant]
US 8301231B2 · Fischell et al. · 2012 [cited by applicant]
US 8380303B2 · Rosenberg et al. · 2013 [cited by applicant]
US 8457725B1 · Fischell et al. · 2013 [cited by applicant]
US 8591455B2 · Mensinger et al. · 2013 [cited by applicant]
US 8760284B2 · Petersen et al. · 2014 [cited by applicant]
US 8897879B2 · Karamanoglu et al. · 2014 [cited by applicant]
US 9185489B2 · Gerber et al. · 2015 [cited by applicant]
US 9186509B2 · Nelson et al. · 2015 [cited by applicant]
US 10543359B2 · Giftakis et al. · 2020 [cited by applicant]
US 10665080B2 · Lee · 2020 [cited by applicant]
US 10805742B2 · Van Gerwen · 2020 [cited by applicant]
US 10869808B2 · Fung et al. · 2020 [cited by applicant]
US 20020099412A1 · Fischell et al. · 2002 [cited by applicant]
US 20070255339A1 · Torgerson · 2007 [cited by examiner]
US 20070255347A1 · Torgerson et al. · 2007 [cited by applicant]
US 20080046016A1 · Ben-David et al. · 2008 [cited by applicant]
US 20090228073A1 · Scholten · 2009 [cited by applicant]
US 20110082376A1 · Huelskamp · 2011 [cited by applicant]
US 20110208455A1 · Tobacman · 2011 [cited by applicant]
US 20120179015A1 · Mann et al. · 2012 [cited by applicant]
US 20120194341A1 · Peichel et al. · 2012 [cited by applicant]
US 20130030497A1 · Karamanoglu · 2013 [cited by applicant]
US 20140213926A1 · Vaidyanathan · 2014 [cited by applicant]
US 20140350636A1 · King · 2014 [cited by applicant]
US 20150297901A1 · Kockx · 2015 [cited by applicant]
US 20160243373A1 · Kalgren · 2016 [cited by applicant]
US 20170360381A1 · McGarraugh · 2017 [cited by applicant]
US 20180001096A1 · Faltys · 2018 [cited by examiner]
US 20180093101A1 · Maile · 2018 [cited by examiner]
US 20190001135A1 · Yoo et al. · 2019 [cited by applicant]
US 20190386498A1 · Higgins · 2019 [cited by applicant]
US 20200054292A1 · Govari · 2020 [cited by applicant]
US 20200113515A1 · O'Connor · 2020 [cited by examiner]
US 20200139139A1 · Crawford · 2020 [cited by applicant]
US 20200228905A1 · Dundas · 2020 [cited by applicant]
US 20200324126A1 · Winstrom · 2020 [cited by applicant]
US 20200381086A1 · Atreja et al. · 2020 [cited by applicant]
US 20200403717A1 · Fishler et al. · 2020 [cited by applicant]
CN 102451520A · 2012 [cited by applicant]
CN 112351813A · 2021 [cited by examiner]
CN112351813-A Translation (Year: 2021). [cited by examiner]
Devinsky et al., “Sudden unexpected death in epilepsy in patients treated with brain-responsive neurostimulation,” Epilepsia, vol. 59, Dec. 11, 2017, pp. 555-561. [cited by applicant]
Holz et al., “Implanted User Interfaces,” CHI '12, Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, May 2012, pp. 503-512. [cited by applicant]
The Week Staff, “The implant that alerts you before a heart attack”, TheWeek.com, Apr. 19, 2012, 7 pp. [cited by applicant]
U.S. Appl. No. 17/645,661, filed Dec. 22, 2021, naming inventors Giftakis et al. [cited by applicant]
U.S. Appl. No. 17/645,669, filed Dec. 22, 2021, naming inventors Giftakis et al. [cited by applicant]
Office Action from U.S. Appl. No. 17/645,661 dated Jul. 20, 2023, 24 pp. [cited by applicant]
Final Office Action from U.S. Appl. No. 17/645,661 dated Dec. 8, 2023, 13 pp. [cited by applicant]
Response to Office Action dated Jul. 20, 2023 from U.S. Appl. No. 17/645,661, filed Oct. 19, 2023, 16 pp. [cited by applicant]
Advisory Action from U.S. Appl. No. 17/645,661 dated Feb. 15, 2024, 3 pp. [cited by applicant]
Office Action from U.S. Appl. No. 17/645,669 dated Feb. 28, 2024, 15 pp. [cited by applicant]
Response to Final Office Action dated Dec. 8, 2023 from U.S. Appl. No. 17/645,661, filed Feb. 8, 2024, 14 pp. [cited by applicant]
Office Action from U.S. Appl. No. 17/645,661 dated May 1, 2024, 7 pp. [cited by applicant]
Response to Office Action from U.S. Appl. No. 17/645,669, filed May 28, 2024, 17 pp. [cited by applicant]
Response to Final Office Action dated May 1, 2024 from U.S. Appl. No. 17/645,661, filed Jul. 25, 2024, 11 pp. [cited by applicant]
Final Office Action from U.S. Appl. No. 17/645,669 dated Sep. 6, 2024, 15 pp. [cited by applicant]
Office Action from U.S. Appl. No. 17/645,661 dated Oct. 15, 2024, 25 pp. [cited by applicant]